Navigation Links
Chemotherapy timing is key to success
Date:5/8/2014

CAMBRIDGE, Mass-- MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.

In studies with mice, the research team showed that this one-two punch, which relies on a nanoparticle that carries two drugs and releases them at different times, dramatically shrinks lung and breast tumors. The MIT team, led by Michael Yaffe, the David H. Koch Professor in Science, and Paula Hammond, the David H. Koch Professor in Engineering, describe the findings in the May 8 online edition of Science Signaling.

"I think it's a harbinger of what nanomedicine can do for us in the future," says Hammond, who is a member of MIT's Koch Institute for Integrative Cancer Research. "We're moving from the simplest model of the nanoparticle just getting the drug in there and targeting it to having smart nanoparticles that deliver drug combinations in the way that you need to really attack the tumor."

Doctors routinely give cancer patients two or more different chemotherapy drugs in hopes that a multipronged attack will be more successful than a single drug. While many studies have identified drugs that work well together, a 2012 paper from Yaffe's lab was the first to show that the timing of drug administration can dramatically influence the outcome.

In that study, Yaffe and former MIT postdoc Michael Lee found they could weaken cancer cells by administering the drug erlotinib, which shuts down one of the pathways that promote uncontrolled tumor growth. These pretreated tumor cells were much more susceptible to treatment with a DNA-damaging drug called doxorubicin than cells given the two drugs simultaneously.

"It's like rewiring a circuit," says Yaffe, who is also a member of the Koch Institute. "When you give the first drug, the wires' connections get switched around so that the second drug works in a much more effective way."'/>"/>

Contact: Andrew Carleen
acarleen@mit.edu
617-253-1682
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Harmless human virus may be able to boost the effects of chemotherapy
2. Nanobubbles plus chemotherapy equals single-cell cancer targeting
3. New biomarker for common lung cancer predicts responses to chemotherapy
4. Scientists uncover strategy able to dramatically reduce chemotherapys side effects
5. Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure
6. New way to kill lymphoma without chemotherapy
7. Changes to DNA on-off switches affect cells ability to repair breaks, respond to chemotherapy
8. Discovery may help prevent chemotherapy-induced anemia
9. An article in Cell reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer
10. Neuroblastoma: Autophagy protects from chemotherapy
11. Chemotherapy before radiotherapy for testicular cancer could reduce long-term side-effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... conducted at Georgia State University suggest that a "fight" between ... kicked off by another type of bacteria, may be linked ... that the "fight" continues after the instigator bacteria have been ... biology at the GSU Center for Inflammation, Immunity and Infection. ...
... first time a surprising and unexpected plasticity in the ... made in early development. Scientists found that ... gene that controls cell fate by regulating other genes, ... progenitor cells in blood forming tissues to become something ...
... bones from what is known as osteoporosis, which may lead ... of the bones results from an imbalance between the normal ... laying down of new bone, an ongoing process for both ... poorly understood reasons, after menopause the resorption of old bone ...
Cached Biology News:Embryonic blood vessels that make blood stem cells can also make beating heart muscles 2Embryonic blood vessels that make blood stem cells can also make beating heart muscles 3Mechanisms for a beneficial effect of moderate alcohol consumption on osteoporosis in women 2
(Date:4/28/2015)... TRIANGLE PARK, N.C., April 28, 2015 United ... its financial results for the first quarter ended ... as compared to the prior year and we ... patients being prescribed our pulmonary arterial hypertension (PAH) ... and Co-Chief Executive Officer. "Since its commercial launch ...
(Date:4/28/2015)...  US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... letter from NASDAQ informing it that it had regained ... In November 2014, the Company received ... submit a plan to regain compliance with the Listing ... in stockholders, equity as of June 30, 2014; (ii) ...
(Date:4/28/2015)... Francisco, CA (PRWEB) April 28, 2015 ... their CLIA-regulated clinical laboratory to provide clinical tests ... Founded in 2012, the biotech startup sparked the ... the public to provide easily accessible information about ... DNA sequencing technology for the microbiome. uBiome has ...
(Date:4/28/2015)... April 28, 2015 IMS is ... bring it to the web and provide greater ... user friendly reporting metrics increase data warehouse’s utility; ... convenient recall and access “on-the-go” makes data analysis ... using client feedback to assist in repository analytics ...
Breaking Biology Technology:United Therapeutics Corporation Reports First Quarter 2015 Financial Results 2United Therapeutics Corporation Reports First Quarter 2015 Financial Results 3United Therapeutics Corporation Reports First Quarter 2015 Financial Results 4United Therapeutics Corporation Reports First Quarter 2015 Financial Results 5United Therapeutics Corporation Reports First Quarter 2015 Financial Results 6United Therapeutics Corporation Reports First Quarter 2015 Financial Results 7United Therapeutics Corporation Reports First Quarter 2015 Financial Results 8United Therapeutics Corporation Reports First Quarter 2015 Financial Results 9United Therapeutics Corporation Reports First Quarter 2015 Financial Results 10Novogen Regains Full Compliance with NASDAQ Listing Rule 2Novogen Regains Full Compliance with NASDAQ Listing Rule 3uBiome Launches Clinical Laboratory 2
... France, January 10 Essilor,of America, Essilor International,s ... the United States with the acquisition,of Interstate Optical ... Interstate,s two laboratories in Mansfield, Ohio and,Indianapolis, Indiana ... has full-year sales of US$26 million and 210 ...
... Sobol Shapiro LLP,( http://www.hbsslaw.com/cellcyte.htm ) today announced ... (OTC Bulletin Board: CCYG) for potential,violations of ... CellCyte,s shares plunged 55 percent,after news reports ... educational and professional credentials., CellCyte,s stock ...
... Jan. 9 Omeros Corporation announced today that,it has ... relating to the proposed initial public offering of shares ... to be sold in the offering,will be offered by ... sole book-running manager. Pacific Growth Equities, LLC will be ...
Cached Biology Technology:Hagens Berman Sobol Shapiro Investigating CellCyte 2Omeros Corporation Files Registration Statement for Proposed Initial Public Offering 2
ID clarifier: platform...
The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
... The four-bay DNA Engine Tetrad ... of interchangeable Alpha units (sample-holder, heat-pump ... numbers of vessels. A Pentium-class computer ... displays current block, sample, and lid ...
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
Biology Products: